CN104602762B - 稳定的培西加南配方 - Google Patents

稳定的培西加南配方 Download PDF

Info

Publication number
CN104602762B
CN104602762B CN201380031162.5A CN201380031162A CN104602762B CN 104602762 B CN104602762 B CN 104602762B CN 201380031162 A CN201380031162 A CN 201380031162A CN 104602762 B CN104602762 B CN 104602762B
Authority
CN
China
Prior art keywords
hydrophilic
topical formulations
formulation
formulations
hlb value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380031162.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN104602762A (zh
Inventor
N·德赛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PLX Pharma Winddown Corp
Original Assignee
Dipexium Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipexium Pharmaceuticals LLC filed Critical Dipexium Pharmaceuticals LLC
Publication of CN104602762A publication Critical patent/CN104602762A/zh
Application granted granted Critical
Publication of CN104602762B publication Critical patent/CN104602762B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201380031162.5A 2012-06-12 2013-06-10 稳定的培西加南配方 Expired - Fee Related CN104602762B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/494,295 2012-06-12
US13/494,295 US8530409B1 (en) 2012-06-12 2012-06-12 Stable pexiganan formulation
PCT/US2013/044957 WO2013188286A1 (en) 2012-06-12 2013-06-10 Stable pexiganan formulation

Publications (2)

Publication Number Publication Date
CN104602762A CN104602762A (zh) 2015-05-06
CN104602762B true CN104602762B (zh) 2017-04-05

Family

ID=49084089

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380031162.5A Expired - Fee Related CN104602762B (zh) 2012-06-12 2013-06-10 稳定的培西加南配方

Country Status (26)

Country Link
US (2) US8530409B1 (https=)
EP (1) EP2858721B1 (https=)
JP (1) JP5876191B2 (https=)
KR (1) KR101622524B1 (https=)
CN (1) CN104602762B (https=)
AU (1) AU2013274561B2 (https=)
BR (1) BR112014030993A2 (https=)
CA (1) CA2876668C (https=)
CY (1) CY1118277T1 (https=)
DK (1) DK2858721T3 (https=)
EA (1) EA028002B1 (https=)
ES (1) ES2599395T3 (https=)
HR (1) HRP20161440T1 (https=)
HU (1) HUE030665T2 (https=)
IL (1) IL236151A (https=)
LT (1) LT2858721T (https=)
MX (1) MX345263B (https=)
NZ (1) NZ703176A (https=)
PL (1) PL2858721T3 (https=)
PT (1) PT2858721T (https=)
RS (1) RS55286B1 (https=)
SG (1) SG11201408055PA (https=)
SI (1) SI2858721T1 (https=)
SM (1) SMT201600411B (https=)
WO (1) WO2013188286A1 (https=)
ZA (1) ZA201500117B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation
GB201505393D0 (en) * 2015-03-30 2015-05-13 Secr Defence Antimicrobal peptide formulations
CN111925430B (zh) * 2020-08-18 2022-05-24 中国海洋大学 抗菌肽及其应用
US20230106943A1 (en) * 2021-09-17 2023-04-06 Peptilogics, Inc. Engineered antimicrobial peptides and usage thereof
KR102773934B1 (ko) * 2021-11-25 2025-02-26 광주여자대학교 산학협력단 Msi-78 펩타이드를 유효성분으로 포함하는 항균용 화장료 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009070564A3 (en) * 2007-11-27 2009-08-27 Macrochem Corporation Compositions and methods for prevention of infection in transcutaneous osseointegrated implants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4169703A (en) * 1978-08-03 1979-10-02 Syntex (U.S.A.) Inc. Oxidative red hair dye
US5912231A (en) * 1989-07-07 1999-06-15 Scripps Clinic And Research Foundation Substitution analogues of magainin peptides
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
AU2005221427B2 (en) * 2004-03-18 2008-09-25 Panacea Biotec Ltd. Novel compositions for topical delivery
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
WO2012174373A1 (en) * 2011-06-16 2012-12-20 Dipexium Pharmaceuticals Methods of treating and inhibiting pathogens with resistance-mechanisms
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009070564A3 (en) * 2007-11-27 2009-08-27 Macrochem Corporation Compositions and methods for prevention of infection in transcutaneous osseointegrated implants

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Oxidation of the N-Terminal Gly-Residue of Peptides: Stress Study of Pexiganan Acetate in a Drug Formulation;B. FEIBUSH, B.C. SNYDER;《PHARMACEUTICAL RESEARCH》;20000201;第17卷;197-204 *
Topical versus Systemic Antimicrobial Therapy for Treating Mildly Infected Diabetic Foot Ulcers: A Randomized, Controlled, Double-Blinded, Multicenter Trial of Pexiganan Cream;BENJAMIN A. LIPSKY ,ET AL;《CLINICAL INFECTIOUS DISEASES》;20081215;第47卷(第12期);1537-1545 *

Also Published As

Publication number Publication date
KR20150043286A (ko) 2015-04-22
ES2599395T3 (es) 2017-02-01
EP2858721A4 (en) 2015-12-09
AU2013274561B2 (en) 2015-09-10
HRP20161440T1 (hr) 2016-12-16
LT2858721T (lt) 2016-12-12
SMT201600411B (it) 2017-01-10
EP2858721A1 (en) 2015-04-15
NZ703176A (en) 2015-08-28
EA028002B1 (ru) 2017-09-29
RS55286B1 (sr) 2017-03-31
BR112014030993A2 (pt) 2017-06-27
AU2013274561A1 (en) 2015-01-22
CA2876668C (en) 2017-12-05
PL2858721T3 (pl) 2017-02-28
US20140038882A1 (en) 2014-02-06
IL236151A0 (en) 2015-01-29
CA2876668A1 (en) 2013-12-19
EA201492280A1 (ru) 2015-05-29
US8530409B1 (en) 2013-09-10
DK2858721T3 (en) 2016-11-28
MX345263B (es) 2017-01-23
ZA201500117B (en) 2016-10-26
SG11201408055PA (en) 2015-01-29
JP5876191B2 (ja) 2016-03-02
CN104602762A (zh) 2015-05-06
IL236151A (en) 2016-06-30
WO2013188286A1 (en) 2013-12-19
PT2858721T (pt) 2016-11-17
HUE030665T2 (en) 2017-05-29
SI2858721T1 (sl) 2017-01-31
HK1210078A1 (en) 2016-04-15
MX2014015199A (es) 2015-08-14
EP2858721B1 (en) 2016-08-17
CY1118277T1 (el) 2017-06-28
JP2015521599A (ja) 2015-07-30
KR101622524B1 (ko) 2016-05-18

Similar Documents

Publication Publication Date Title
JP5474827B2 (ja) 皮膚、粘膜、頭皮または爪の処置、保護または洗浄において有用なペプチド誘導体
CN104602762B (zh) 稳定的培西加南配方
US10919935B2 (en) Antimicrobial peptide derived from myxinidin peptide and uses thereof
US20050148495A1 (en) Methods and materials including for treating acne
CN107224426A (zh) 一种含有夫西地酸的外用乳膏组合物
JP2010517987A (ja) 塩基性ペプチド及びその複合型抗細菌−抗真菌剤としての使用
TWI896741B (zh) 用於修復皮膚創傷或黏膜損傷的多肽及其應用
KR102158036B1 (ko) Pseudin-2 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
HK1210078B (en) Stable pexiganan formulation
US20180289656A1 (en) Compositions and methods to treat urinary tract infections
US11117931B2 (en) Antimicrobial peptide derived from Hp1404 peptide and uses thereof
CN113134075A (zh) 一种抗菌肽乳膏及其制备方法
KR20220099306A (ko) Hylin a1 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도
WO2019079150A1 (en) COMPOSITIONS AND METHODS FOR TREATING ATOPIC DERMATITIS
US20080107717A1 (en) Methods and materials including treating acne related applications
KR20220111039A (ko) Pep27 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1210078

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1210078

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170405

Termination date: 20180610